Diabetes and progression of coronary calcium under the influence of statin therapy

Haffner, 1998, Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction, N. Engl. J. Med., 339, 229, 10.1056/NEJM199807233390404 Haffner, 1999, Reduced coronary events in simvastatin-treated patients with coronary heart disease and diabetes or impaired fasting glucose levels: subgroup analyses in the Scandinavian Simvastatin Survival Study, Arch. Intern. Med., 159, 2661, 10.1001/archinte.159.22.2661 Gotto, 2002, Lipid management in diabetic patients: lessons from prevention trials, Am. J. Med., 112, 19S, 10.1016/S0002-9343(02)01086-0 Farkouh, 2001, Diabetes and cardiovascular disease, 2197 O'Rourke, 2000, American College of Cardiology/American Heart Association Expert Consensus Document on electron-beam computed tomography for the diagnosis and prognosis of coronary artery disease, J. Am. Coll. Cardiol., 36, 326, 10.1016/S0735-1097(00)00831-7 Khaleeli, 2001, The use of electron beam computed tomography in diabetics, Am. Heart J., 141, 637, 10.1067/mhj.2001.113224 Budoff, 2000, Rates of progression of coronary calcium by electron beam tomography, Am. J. Cardiol., 86, 8, 10.1016/S0002-9149(00)00820-1 Qu, 2003, Value of coronary artery calcium scanning by computed tomography predicting coronary heart disease in diabetic subjects, Diabetes Care, 26, 905, 10.2337/diacare.26.3.905 Kondos, 2003, Electron-beam tomography coronary artery calcium and cardiac events: a 37-month follow-up of 5,635 initially asymptomatic low- to intermediate-risk adults, Circulation, 107, 2571, 10.1161/01.CIR.0000068341.61180.55 Arad, 2003, Coronary calcification, coronary risk factors, and atherosclerotic cardiovascular disease events. The St. Francis Heart Study, J. Am. Coll. Cardiol., 41, 6 Budoff, 2001, Coronary artery disease progression assessed by electron-beam computed tomography, Am. J. Cardiol., 88, 46E, 10.1016/S0002-9149(01)01767-2 1994, Randomized trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S), Lancet, 344, 1383 Sacks, 1996, The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels, N. Engl. J. Med., 335, 1001, 10.1056/NEJM199610033351401 Kane, 1990, Regression of coronary atherosclerosis during treatment of familial hypercholesterolemia with combined drug regimens, JAMA, 264, 3007, 10.1001/jama.1990.03450230043027 Brown, 1990, Regression of coronary artery disease as a result of intensive lipid-lowering therapy in men with high levels of apolipoprotein B, N. Engl. J. Med., 323, 1289, 10.1056/NEJM199011083231901 Callister, 1998, Effect of HMG-CoA reductase inhibitors on coronary artery disease as assessed by electron-beam computed tomography, N. Engl. J. Med., 339, 1972, 10.1056/NEJM199812313392703 2001, Executive summary of the third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III), JAMA, 285, 2486, 10.1001/jama.285.19.2486 Bakhsheshi, 2000, Preview method for electron beam scanning of the coronary arteries, Acad. Radiol., 7, 620, 10.1016/S1076-6332(00)80578-4 Agatston, 1990, Quantification of coronary artery calcium using ultrafast computed tomography, J. Am. Coll. Cardiol., 15, 827, 10.1016/0735-1097(90)90282-T Achenbach, 2001, Variability of repeated coronary calcium measurements by electron beam tomography, Am. J. Cardiol., 87, 210, 10.1016/S0002-9149(00)01319-9 Lindvall, 1999, Comparison of diabetic and non-diabetic patients referred for coronary angiography, Int. J. Cardiol., 70, 33, 10.1016/S0167-5273(99)00045-5 Pyorala, 1997, Cholesterol lowering with simvastatin improves prognosis of diabetic patients with coronary heart disease: a subgroup analysis of the Scandinavian Simvastatin Survival Study (4S), Diabetes Care, 20, 614, 10.2337/diacare.20.4.614 2002, MRC/BHF heart protection study of cholesterol lowering with simvastatin in 20536 high-risk individuals: a randomised placebo-controlled trial, Lancet, 360, 7, 10.1016/S0140-6736(02)09327-3 Diabetes Atherosclerosis Intervention Study Investigators, 2001, Effect of fenofibrate on progression of coronary-artery disease in type 2 diabetes: the Diabetes Atherosclerosis Intervention Study, a randomized study, Lancet, 357, 905, 10.1016/S0140-6736(00)04209-4 Raggi, 2003, Progression of coronary calcification on serial electron beam tomography scanning is greater in patients with future myocardial infarction, Am. J. Cardiol., 92, 827, 10.1016/S0002-9149(03)00892-0 Wagenknecht, 2001, Familial aggregation of coronary artery calcium in families with type 2 diabetes, Diabetes, 50, 861, 10.2337/diabetes.50.4.861 Elkeles, 2004, The association of coronary calcium score and conventional cardiovascular risk factors in asymptomatic patients with type 2 diabetes (The PREDICT Study), Diabet. Med., 21, 1129, 10.1111/j.1464-5491.2004.01409.x Snell-Bergeon, 2003, Progression of coronary artery calcification in type 1 diabetes: the importance of glycemic control, Diabetes Care, 26, 2923, 10.2337/diacare.26.10.2923 Nasir, 2003, Electron beam CT vs. helical CT scans of coronary arteries: current utility and future directions, Am. Heart J., 146, 949, 10.1016/S0002-8703(03)00450-2 Budoff, 2003, Point: diabetic patients and coronary calcium, Diabetes Care, 26, 541, 10.2337/diacare.26.2.541